First Interstate Bank Supernus Pharmaceuticals, Inc. Transaction History

First Interstate Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$25.47 - $33.37 $11,945 - $15,650	-469 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$29.96 - $38.87 $14,051 - $18,230	469 New	469 $16,000
Q2 2018 Jul 27, 2018	SELL	$44.1 - $59.85 $17,640 - $23,940	-400 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$36.75 - $49.65 $14,700 - $19,860	400	400 $16,000

284

60.5M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.09B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

Stay updated on First Interstate Bank with notifications on news.